Source Kit
October 1, 1999
Source Kit
• Edward F. Philbin, MD, Section of Heart Failure and Cardiac Transplantation, Henry Ford Hospital, Detroit. Telephone: (313) 916-2895. E-mail: [email protected].
• Gordon Ewy, MD, Chief of Cardiology, University of Arizona Health Sciences Center, Tucson, AZ. Telephone: (520) 694- 0111.
Bobby Miller, Supervisor, Optum Disease Management Program, Dayton, OH. Telephone: (937) 220-9114.
• Douglas Chapman, MD, Director, The Heart Failure Center, Alegent Medical Center, Omaha, NE. Telephone: (402) 572-3300.
• Kenneth McDonagh, MD, Medical Director, disease management program, AstraZeneca Pharmaceuticals, Wilmington, DE. Telephone: (302) 886-3000. E-mail: www.astrazeneca-us.com.
• Evadell Tangquist, RN, Patient Education Coordinator, Northwest Medical Center, Thief River Falls, MN. Telephone: (218) 681-4240, ext. 446.
• Elgin K. Kennedy, MD, Hillsborough, CA. Telephone: (415) 348-3647.
• Santosh G. Menon, MD, Division of Cardiology, University of Kentucky, Lexington. Telephone: (606) 257-3632.
• David S. Roffman, PharmD, BCPS, Associate Professor of Pharmacy Practice and Science, School of Pharmacy, University of Maryland, Baltimore. Telephone: (410) 706-3215.
• Raymond Urbanski , MD, Associate Medical director, AstraZeneca Pharmaceuticals, Wilmington, DE. Telephone: (302) 886-3000. E-mail: www.astrazeneca-us.com.
• Silviu Itescu, MD, Cardiothoracic Surgeon, Columbia-Presbyterian Medical Center, New York City. Telephone: (212) 305-2500. E-mail: [email protected].
• Mehmet C. Oz, MD, Cardiothoracic Surgeon, Columbia-Presbyterian Medical Center, New York City. Telephone: (212) 305-4434. E-mail: [email protected].